View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EQS-News: ADS-TEC Energy (ADSE) gibt die Ergebnisse für das Gesamtjahr...

Emittent / Herausgeber: ADS-TEC Energy GmbH / Schlagwort(e): Jahresergebnis ADS-TEC Energy (ADSE) gibt die Ergebnisse für das Gesamtjahr 2023 bekannt und informiert über den aktuellen Geschäftsverlauf 30.04.2024 / 14:29 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. NÜRTINGEN, Deutschland - 30. April 2024 – ADS-TEC Energy plc (“ADS-TEC Energy,” “ADS-TEC ,” “Company,” “we,” “our” or “us”) (NASDAQ: ADSE), ein weltweit führender Anbieter von batteriegepufferter, ultraschneller Ladetechnologie, gibt heute die geprüften Finanzergebnisse f...

 PRESS RELEASE

EQS-News: GEA Aktionäre stimmen mit überwältigenden 98.4% dem Klimapla...

EQS-News: GEA Group Aktiengesellschaft / Schlagwort(e): Hauptversammlung/ESG GEA Aktionäre stimmen mit überwältigenden 98.4% dem Klimaplan 2040 zu (News mit Zusatzmaterial) 30.04.2024 / 14:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. GEA Aktionäre stimmen mit überwältigenden 98,4% dem Klimaplan 2040 zu Düsseldorf, 30. April 2024 – In einer wegweisenden Abstimmung haben die Aktionärinnen und Aktionäre der GEA Group AG auf der heutigen Hauptversammlung mit überwältigender Mehrheit dem vorgelegten Klimaplan 2040 zugestimmt. Mit di...

 PRESS RELEASE

EQS-News: Shareholders approve GEA’s Climate Transition Plan 2040 by a...

EQS-News: GEA Group Aktiengesellschaft / Key word(s): AGM/EGM/ESG Shareholders approve GEA’s Climate Transition Plan 2040 by an overwhelming 98.4% (news with additional features) 30.04.2024 / 14:30 CET/CEST The issuer is solely responsible for the content of this announcement. Shareholders approve GEA’s Climate Transition Plan 2040 by an overwhelming 98.4% Düsseldorf, April 30, 2024 – In a groundbreaking vote at today’s Annual General Meeting, GEA Group AG’s shareholders approved by an overwhelming majority the Climate Transition Plan 2040 presented to them. This consult...

 PRESS RELEASE

EQS-News: ADS-TEC Energy (ADSE) Reports Full-Year Fiscal 2023 Results ...

Issuer: ADS-TEC Energy GmbH / Key word(s): Annual Results ADS-TEC Energy (ADSE) Reports Full-Year Fiscal 2023 Results and Provides Business Update 30.04.2024 / 14:29 CET/CEST The issuer is solely responsible for the content of this announcement. NÜRTINGEN, Germany – April 30th, 2024 – ADS-TEC Energy plc (plc (“ADS-TEC Energy,” “ADS-TEC ,” “Company,” “we,” “our” or “us”) (NASDAQ: ADSE), a global leader in battery-buffered, ultra-fast charging technology, today announced audited financials for FY 2023 and is pleased to provide an operational update on the recent financial p...

 PRESS RELEASE

Fractyl Health Announces Multiple Presentations at the Upcoming Digest...

Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting At DDG, Fractyl Health will present new clinical updates on its ongoing real-world registry study of Revita® in patients with T2D in Germany At DDW, Fractyl Health will provide an oral presentation from its Rejuva® platform with new preclinical data demonstrating the potential of GLP-1 based pancreatic gene therapy (GLP-1 PGTx) to durably reduce liver fat in the diet-induced obesity model BURLINGTON, Mass., April 30, 202...

FIMA Research
  • FIMA Research

Fima Daily Insight 30 April 2024

Please find enclosed our daily market report.Market CommentCroatia Plava Laguna proposes EUR 15 per share dividend (DIVY 4%) HPB’s net profit surges by 33% in Q1 Dalekovod swings to net profit in Q1 ZABA reports 25% higher net profit YoY in Q1 Slovenia SBI TOP up in mixed trading Romania OMV Petrom sets new all time high today after posting Q1'24 results Bulgaria Shelly Group widens Q1 non-cons net loss

 PRESS RELEASE

VCI Global Announces 145% Revenue Growth for Fiscal Year 2023 Financia...

VCI Global Announces 145% Revenue Growth for Fiscal Year 2023 Financial Results KUALA LUMPUR, Malaysia, April 30, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), a diversified holding company focusing on consulting and technology, is proud to announce its audited financial results for the financial year ended December 31, 2023 (the “Financial Results”). VCI Global delivered a record high total revenue of $19.8 million for fiscal year 2023, representing a 145% YoY growth.Gross profit achieved significant growth of 159% YoY, reaching...

 PRESS RELEASE

Global Water Resources Declares Monthly Dividend

Global Water Resources Declares Monthly Dividend PHOENIX, April 30, 2024 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared, under its dividend policy a monthly cash dividend in the amount of $0.02508 per common share (an annualized dividend rate of $0.30096 per share). The dividend will be payable on May 31, 2024, to holders of record at the close of business on May 17, 2024. About Global Water Resources Global Water Resources, Inc. is a leading water resource management company that owns and operates 31 syst...

Asseco Poland S.A.: 1 director

A director at Asseco Poland S.A. bought 6,944 shares at 78.970PLN and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

IOI Properties Group Berhad: 1 director

A director at IOI Properties Group Berhad sold 46,152,700 shares at 2.058MYR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Bactiguard Holding AB: 1 director

A director at Bactiguard Holding AB bought 100,000 shares at 68.457SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Aldani Master Capital S.A: 1 director

A director at Aldani Master Capital S.A sold 67,105 shares at 4.540RON and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

ABGSC Chemicals Research ... (+3)
  • ABGSC Chemicals Research
  • Adrian Gilani
  • Henric Hintze

Better than expected, comps ease from here

GC&MP outperforms, NW&FT takes a breather, FW lags behind. Sales decline, but EBIT and cash flow better than expected. Liquidity stabilised, new customers and cost control bode well.

 PRESS RELEASE

Rigetti Computing to Report First Quarter 2024 Financial Results and H...

Rigetti Computing to Report First Quarter 2024 Financial Results and Host Conference Call on May 9, 2024 BERKELEY, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. ("Rigetti" or the "Company") (Nasdaq: RGTI), a pioneer in hybrid quantum-classical computing, announced today that it will release first quarter 2024 results on Thursday, May 9, 2024 after market close. The Company will host a conference call to discuss its financial results and provide an update on its business operations at 5:00 p.m. ET the same day. Key details regarding the call are as follows: Call Date...

 PRESS RELEASE

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm an...

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss -- The Phase 2b study planned to be conducted in 15 clinical sites in the United States -- -- Topline clinical data expected in the fourth quarter calendar year 2024 -- MIAMI, FL, April 30, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced...

 PRESS RELEASE

KULR Technology Group and Amprius Technologies Form Strategic Partners...

KULR Technology Group and Amprius Technologies Form Strategic Partnership for Advanced Battery Packs KULR ONE Space and KULR ONE Guardian Platforms to Integrate Amprius Silicon Anode SA10 Cells SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- (NYSE American: KULR) (the "Company" or "KULR"), a global leader in safe and high performance energy storage solutions, today announced a leap forward in battery technology tailored for defense and space applications as KULR Technology Group (NYSE: KULR) and (NYSE: AMPX) officially announce their strategic partnership. This collaboration heralds the ...

 PRESS RELEASE

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A...

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares WEST ORANGE, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- BEL FUSE INC. (NASDAQ:BELFA) and (NASDAQ:BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company's Class A common shares and $0.07 per share on the Company's Class B common shares. Cash dividends for Class A and Class B common shares are payable on August 1, 2024 to shareholders of record on July 15, 2024. Bel currently has approximately 12,620,000 common shares outstandi...

 PRESS RELEASE

AgriFORCE Receives Australian Patent Allowance for Its High Fiber, Hig...

AgriFORCE Receives Australian Patent Allowance for Its High Fiber, High Protein Low Carbohydrate Flour and Technology VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP) focused AgTech company, announces that IP Australia, the intellectual property branch of the Australian government has granted the Company a standard patent for its high fiber, high protein, low carbohydrate flour. Patent number 2018215090, titled, “High fiber, high protein, low carbohydrate flour, sweetened liq...

 PRESS RELEASE

Inuvo Announces Enhancements to its Audience Discovery Portal

Inuvo Announces Enhancements to its Audience Discovery Portal IntentKey AI can now associate any product, brand, or service to trending events LITTLE ROCK, Ark., April 30, 2024 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), provider of the first generative artificial intelligence (AI) advertiser solution made specifically for brands and agencies, today announces a significant enhancement to its Audience Discovery Portal, the latest version of a first-of-its-kind intelligence capable of instantly generating marketing audience insights. Powered by IntentKey AI, a proprietary larg...

 PRESS RELEASE

Wave Life Sciences Announces Approval of First Clinical Trial Applicat...

Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) Proof-of-mechanism data for WVE-006 in individuals with AATD remain on track for 2024 CAMBRIDGE, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the approval of its first clinical trial application (CTA) for its RestorAATion-2 clinical trial of WVE-006...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch